Nicholas J. Hart
Distinguished in Cramp-Fasciculation Syndrome

Nicholas J. Hart

Lane Fox Respiratory Unit, 
London, ENG, GB 
Distinguished in Cramp-Fasciculation Syndrome
Lane Fox Respiratory Unit, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Nicholas Hart practices in London, United Kingdom. Mr. Hart is rated as a Distinguished expert by MediFind in the treatment of Cramp-Fasciculation Syndrome. His top areas of expertise are Obesity Hypoventilation Syndrome (OHS), Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, Gastrostomy, and Colostomy.

His clinical research consists of co-authoring 206 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Cramp-Fasciculation Syndrome.

Gender
Male

Locations

Lane Fox Respiratory Unit, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD
Extra-corporeal CO2 Removal as an Adjunct to Non-Invasive Ventilation in Acute Severe Exacerbations of COPD
Enrollment Status: Completed
Publish Date: August 11, 2021
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-blind (Sponsor Unblind), Placebo-controlled, Multi-centred Phase IIa Study to Evaluate the Safety and Efficacy of 13 Weeks of Once Daily Oral Dosing of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Older Men and Post Menopausal Women With COPD and Muscle Weakness, Participating in Home Exercise
A Randomized, Double-blind (Sponsor Unblind), Placebo-controlled, Multi-centred Phase IIa Study to Evaluate the Safety and Efficacy of 13 Weeks of Once Daily Oral Dosing of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Older Men and Post Menopausal Women With COPD and Muscle Weakness, Participating in Home Exercise
Enrollment Status: Completed
Publish Date: July 15, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

206 Total Publications

Symptomatic improvement in patients with excessive dynamic airway collapse (EDAC) following initiation of positive airway pressure therapy.
Symptomatic improvement in patients with excessive dynamic airway collapse (EDAC) following initiation of positive airway pressure therapy.
Journal: Chronic respiratory disease
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hart's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile